The Federal Circuit recently weighed in on an interference proceeding between the University of California (“UC”) and the Broad Institute over the use of CRISPR-Cas9 technology. The Court affirmed a Patent Trial and Appeal Board (“Board”) decision finding there was no interference-in-fact between UC’s patent application and the claims of twelve patents and one application owned by Institute… Considering the evidence of simultaneous invention, along with evidence regarding the state of the art, inventor statements, and application of similar technologies, the Court concluded the Board’s finding was supported by substantial evidence.
The post Federal Circuit Affirms Board: No Interference-in-Fact for CRISPR-Cas9 Technology appeared first on IPWatchdog.com | Patents & Patent Law.
Federal Circuit Affirms Board: No Interference-in-Fact for CRISPR-Cas9 Technology
No Comments
Patent
- Enablement
- Fee Shifting
- Litigation
- Federal Circuit Invalidates Mobile Device Targeted Ad Claims on Section 101 Cross-Appeal
- Patent Filings Roundup: Microsoft Battles Daedalus Blue; Intel Gears Up for First-to-File Fight; Electric Blanket Boogaloo
- Eleven Million Patents: Milestones in the History of Invention
- Assessing the Damage from Our COVID Technology Giveaway
- PPAC Meeting: Filings Down Less Than Expected Overall, Office Calls on Congress to Release Previously Collected Fees
Recent Posts
- Federal Circuit Invalidates Mobile Device Targeted Ad Claims on Section 101 Cross-Appeal
- Patent Filings Roundup: Microsoft Battles Daedalus Blue; Intel Gears Up for First-to-File Fight; Electric Blanket Boogaloo
- Eleven Million Patents: Milestones in the History of Invention
- Assessing the Damage from Our COVID Technology Giveaway
- PPAC Meeting: Filings Down Less Than Expected Overall, Office Calls on Congress to Release Previously Collected Fees